Drugs / Anti-HER2 CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02713984 | Mar 2016 → Jul 2019 | breast cancer, colorectal cancer, gastric cancer, glioma +3 | Zhi Yang | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-HER2 CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02713984 ↗ |
| Modality | Cell therapy | “Chimeric antigen receptor T cells (CAR-T) therapy” NCT02713984 ↗ |